๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK ยท Real-Time Price ยท USD
13.35
+0.50 (3.89%)
Nov 18, 2026, 12:00 PM EST - Market open

Anika Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
123.43112.82119.91120.79113.83147.79
Revenue Growth
9.42%-5.91%-0.73%6.12%-22.98%13.29%
Gross Profit
78.2663.8176.682.5373.2289.41
Operating Income
-0.11-11.05-4.50.843.67-12.02
Net Income
-1.77-10.88-56.39-82.67-14.864.13
Earnings Per Share
-0.13-0.76-3.83-5.64-1.020.28
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
74.9570.0682.4586.9183.75113.83
Europe
25.5222.2119.417.3117.2319.58
Other
22.9720.5518.0616.5712.8514.38
Total
123.43112.82119.91120.79113.83147.79

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
44.9657.4855.6368.7486.3394.39
Total Debt
26.1526.2525.9327.7430.8920.95
Net Cash (Debt)
18.8131.2329.74155.4473.43
Net Cash Growth
-43.83%5.17%-27.57%-26.05%-24.51%-3.19%
Net Cash Per Share
1.382.182.022.803.815.02

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
7.4811.195.4-1.794.418.4
Capital Expenditures
-5.19-6.83-7.73-5.43-7.49-5.14
Free Cash Flow
2.34.36-2.33-7.22-3.083.25
Free Cash Flow Growth
254.17%-----71.55%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.40%56.56%63.89%68.33%64.33%60.49%
Operating Margin
-0.09%-9.79%-3.75%0.70%3.22%-8.13%
Pretax Margin
-0.81%-8.25%-2.31%2.61%3.80%1.64%
Profit Margin
-1.43%-9.64%-47.02%-68.44%-13.05%2.80%
FCF Margin
1.86%3.87%-1.94%-5.97%-2.70%2.20%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----125.13
Forward PE
32.1453.3939.1972.0872.08112.55
P/FCF Ratio
75.0031.77---158.96
PS Ratio
1.391.232.012.753.803.50